Literature DB >> 2748452

Prognostic significance of vimentin positivity in formalin-fixed renal cell carcinomas.

K Donhuijsen1, S Schulz.   

Abstract

The aim of the present study was to determine whether vimentin immunoreactivity was of prognostic relevance using the PAP-method on formalin-fixed tissue from 94 renal cell carcinomas (RCC). The vimentin expression was compared with tumour stage, histological grade of malignancy, and survival data. In 28 cases (30%), the tumour cells showed a vimentin positivity. This group showed a more unfavourable prognosis than the vimentin-negative group. Differences were also seen in stage T 3 tumours. The percentages of vimentin-positive cases increased with the grade of malignancy. Vimentin-positive cases showed a particularly unfavourable course in the G 3-group of carcinomas. In individual cases, the prognostic value of vimentin expression is limited by a decreased sensitivity and specificity. In addition, the presence of immunoreactivity apparently is not independent of conventional histological criteria of tumour grading.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2748452     DOI: 10.1016/S0344-0338(89)80088-3

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

Review 1.  Pattern recognition and arrays: the times are a-changing.

Authors:  D Shibata
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

Authors:  H Moch; P Schraml; L Bubendorf; M Mirlacher; J Kononen; T Gasser; M J Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  Expression of the human nephron differentiation molecules in renal cell carcinomas.

Authors:  D Droz; D Zachar; L Charbit; J Gogusev; Y Chrétein; L Iris
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.

Authors:  W Domagala; J Lasota; J Bartkowiak; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

5.  Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.

Authors:  W Domagala; J Lasota; A Dukowicz; M Markiewski; G Striker; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

6.  Pathway signature and cellular differentiation in clear cell renal cell carcinoma.

Authors:  Han W Tun; Laura A Marlow; Christina A von Roemeling; Simon J Cooper; Pamela Kreinest; Kevin Wu; Bruce A Luxon; Mala Sinha; Panos Z Anastasiadis; John A Copland
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

7.  Distribution of cytokeratins, vimentin and desmoplakins in normal renal tissue, renal cell carcinomas and oncocytoma as revealed by immunofluorescence microscopy.

Authors:  A Beham; M Ratschek; K Zatloukal; C Schmid; H Denk
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Vimentin expression in 98 breast cancers with medullary features and its prognostic significance.

Authors:  S Holck; L Pedersen; T Schiødt; K Zedeler; H Mouridsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Increased phosphorylation of vimentin in noninfiltrative meningiomas.

Authors:  Ali Bouamrani; Claire Ramus; Emmanuel Gay; Laurent Pelletier; Myriam Cubizolles; Sabine Brugière; Didier Wion; François Berger; Jean-Paul Issartel
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.